Iceland· IS-761982
Alcaine
A proxymetacaine product containing proxymetacainum inn hýdróklóríð, registered in Iceland by Alcon Nordic A/S. The same ATC class is registered in 10 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Proxymetacaine is registered in 10 of 19 countries.
Countries holding a registration under ATC S01HA04 (proxymetacaine), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 6 of them publish a price we can compare per daily dose
Proxymetacaine · ATC S01HA04
10 / 19 countries
- Belgiumprice
- Canada
- Germany
- Icelandprice
- Ireland
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Proxymetacainum INN hýdróklóríð
- Manufacturer
- Alcon Nordic A/S
- Country
- Iceland (IS)
- ATC code
- S01HA04
- ATC class
- Proxymetacaine
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean13284515 ml x1 glasISK 2238
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
20 interactions on record for proxymetacaine.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Proxymetacaine · interactions on record
20 records
- 20 moderate
Most severe, free to view
- MetoclopramideA03FA01moderate
- SulfamethizoleB05CA04moderate
- LidocaineC01BB01moderate
- Silver sulfadiazineD06BA01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Proxymetacaine in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesAlcaineAlcon Laboratories, Inc.
- PolandAlcaineInPharm Sp. z o.o.
- NorwayAlcaineAlcon Nordic A/S
- GermanyProparakain-PosUrsapharm Arzneimittel Gmbh
- BelgiumAlcaine 0.5 %Alcon
- IrelandMinims Proxymetacaine hydrochloride 0.5% w/v, Eye Drops, SolutionBausch + Lomb Ireland Limited
- United KingdomMinims proxymetacaine 0.5% eye drops 0.5ml unit doseBausch & Lomb UK Ltd
- CanadaALCAINEALCON CANADA INC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Alcaine
- Bulgaria · Алкаин
- Cyprus · Alcaine
- Germany · Proparakain-Pos
- United Kingdom (Northern Ireland) · Proxymetacaine Hydrochloride Minims Bausch & Lomb Uk
- Greece · Alcaine
- Ireland · Minims
- Lithuania · Alcaine
- Norway · Alcaine
- Poland · Alcaine
- Slovenia · Alcaine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3866b0b5-5dad-48ce-9515-9122dc1059af GET /v1/drugs/3866b0b5-5dad-48ce-9515-9122dc1059af?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Augndropar, lausn",
"source": "lyfjastofnun",
"atc_raw": "S01HA04",
"marketed": true,
"strength": "5 mg/ml",
"ma_number": "761982",
"substance": "Proxymetacainum INN hýdróklóríð",
"other_info": null,
"legal_status": "(R) Lyfseðilsskylt",
"ma_issued_serial": "28068"
}See everything about proxymetacaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.